E-LIB Suche - Ergebnisse für: Girardi, Daniel M

1

Systemic therapy issues: Immunotherapy in nonmetastatic uro..:

Nadal, Rosa ; Apolo, Andrea B. ; Girardi, Daniel M...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 1 - p. 27-34 , 2023

Link: https://doi.org/10.1016/..

2

Systemic therapy in bladder preservation:

Girardi, Daniel M. ; Ghatalia, Pooja ; Singh, Parminder...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 1 - p. 39-47 , 2023

Link: https://doi.org/10.1016/..

3

Systemic Therapy for Advanced Hepatocellular Carcinoma: Cur..:

Girardi, Daniel M. ; Sousa, Lara P. ; Miranda, Thiago A....
Cancers. 15 (2023) 6 - p. 1680 , 2023

Link: https://doi.org/10.3390/..

4

Cabozantinib plus Nivolumab Phase I Expansion Study in Pati..:

Girardi, Daniel M. ; Niglio, Scot A. ; Mortazavi, Amir...
Clinical Cancer Research. 28 (2022) 7 - p. 1353-1362 , 2022

Link: https://doi.org/10.1158/..

5

Immunotherapy and Targeted Therapy for Hepatocellular Carci..:

Girardi, Daniel M. ; Pacífico, Jana Priscila M. ; Guedes de Amorim, Fernanda P. L....
Pharmaceuticals. 14 (2020) 1 - p. 28 , 2020

Link: https://doi.org/10.3390/..

6

Clinical benefit and radiological response with BRAF inhibi..:

Fernandes, Gustavo S. ; Girardi, Daniel M. ; Bernardes, João Paulo G...
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

7

Second-Line Treatment for Advanced Pancreatic Adenocarcinom..:

Girardi, Daniel M. ; Faria, Luiza Dib B. B. ; Teixeira, Marcela C....
Journal of Gastrointestinal Cancer. 50 (2018) 4 - p. 860-866 , 2018

Link: https://doi.org/10.1007/..

8

Chemoradiotherapy versus chemotherapy as adjuvant treatment..:

Girardi, Daniel M. ; de Lima, Mariana A. ; Pereira, Gabriel C. B....
BMC Cancer. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

9

Next-generation Sequencing-based genomic profiling: Fosteri..:

Fernandes, Gustavo S. ; Marques, Daniel F. ; Girardi, Daniel M....
Clinics. 72 (2017) 10 - p. 588-594 , 2017

Link: https://doi.org/10.6061/..

10

Unraveling molecular pathways of poorly differentiated neur..:

Girardi, Daniel M. ; Silva, Andrea C.B. ; Rêgo, Juliana Florinda M...
Cancer Treatment Reviews. 56 (2017) - p. 28-35 , 2017

Link: https://doi.org/10.1016/..

11

Systemic Therapy for Advanced Hepatocellular Carcinoma: Cur..:

Girardi, Daniel M ; Sousa, Lara P ; Miranda, Thiago A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046570/. , 2023

Link: http://www.ncbi.nlm.nih...

12

Cabozantinib plus Nivolumab Phase I Expansion Study in Pati..:

Girardi, Daniel M ; Niglio, Scot A ; Mortazavi, Amir...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365339/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Immunotherapy and Targeted Therapy for Hepatocellular Carci..:

Girardi, Daniel M ; Pacífico, Jana Priscila M ; Guedes de Amorim, Fernanda P. L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824026/. , 2020

Link: http://www.ncbi.nlm.nih...

14

Phase I Study of Cabozantinib and Nivolumab Alone or With I..:

Apolo, Andrea B ; Nadal, Rosa ; Girardi, Daniel M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605393/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Next-generation Sequencing-based genomic profiling: Fosteri..:

Fernandes, Gustavo S ; Marques, Daniel F ; Girardi, Daniel M...
https://www.revistas.usp.br/clinics/article/view/141013/136079. , 2017

Link: https://www.revistas.usp..